Viropharma, Inc. (VPHM) Tops Q4 EPS by 7c; Guides FY Sales In-Line
Tweet Send to a FriendGet Alerts VPHM Hot Sheet
Price: $25.88 +1.01%
EPS Growth %: -2.3%
Financial Fact:
Other operating expenses: 2.08M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -2.3%
Financial Fact:
Other operating expenses: 2.08M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade VPHM Now!
Viropharma, Inc. (NASDAQ: VPHM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $106.5 million versus the consensus estimate of $103.06 million.
Viropharma, Inc. sees FY2013 revenue of $450-475 million, versus the consensus of $460.07 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Viropharma, Inc. sees FY2013 revenue of $450-475 million, versus the consensus of $460.07 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Leading Brands Inc New (LBIX) Reports Breakeven Q4 Loss
- Kohls Corp. (KSS) Tops Q1 EPS by 8c; Comps Down 1.9%; Guides Q2
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
